Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Shimin Hu, Rashmi Kanagal-Shamanna, Sanam Loghavi, Keyur Patel
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia · 2022 · 3,300 citations · Vasiliki Leventaki, Jeffrey Medeiros, Roberto Miranda
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood · 2022 · 2,489 citations · Sa Wang, Carlos Bueso-Ramos
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.
Nature · 2024 · 489 citations · Huan Mo
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.
Nature · 2025 · 164 citations · J Bryan
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood · 2021 · 650 citations · Jeffrey Jorgensen
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.
Blood · 2026 · 47 citations · Sa Wang
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 157 citations · Kelly Chien, Keyur Patel